公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) | Davis T.M.E.; Mulder H.; Lokhnygina Y.; Aschner P.; LEE-MING CHUANG ; Raffo Grado C.A.; Standl E.; Peterson E.D.; Holman R.R.; for the TECOS Study Group | Diabetes, Obesity and Metabolism | 22 | 21 | |
2012 | Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: An observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial | Preiss D.; Thomas L.E.; Sun J.-L.; Haffner S.M.; Holman R.R.; Standl E.; Leiter L.A.; Mazzone T.; Rutten G.E.; Tognoni G.; Martinez F.A.; FU-TIEN CHIANG ; Califf R.M.; McMurray J.J. | BMJ Open | 22 | 20 | |
2013 | Predictors of stroke in patients with impaired glucose tolerance: Results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial | Preiss D.; Giles T.D.; Thomas L.E.; Sun J.-L.; Haffner S.M.; Holman R.R.; Standl E.; Mazzone T.; Rutten G.E.; Tognoni G.; FU-TIEN CHIANG ; McMurray J.J.V.; Califf R.M. | Stroke | 8 | 7 |